278: Merger Mondays, Ozempic panic, & CRISPR'd pigs
The Readout Loud
00:00
Introduction
The hosts discuss the multi-billion dollar acquisition of Marathi Therapeutics by Bristol Myers-Grib and its implications for the biotech industry. They also cover other news in the field, including ozempic, CRISPR technology, and the ongoing saga of Nash, and promote the annual STAT Summit.
Transcript
Play full episode
